• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血液透析期间血浆醛固酮的控制

Control of plasma aldosterone during chronic hemodialysis.

作者信息

Studer A, Záruba K, Grimm J, Kuhlmann U, Siegenthaler W, Vetter W

出版信息

Clin Nephrol. 1980 Apr;13(4):172-6.

PMID:6991183
Abstract

To investigate the effect of chronic hemodialysis (CH) on adrenal aldosterone release plasma aldosterone (PA), plasma renin activity (PRA), plasma cortisol (PC) and the serum concentrations of potassium (K) and sodium (Na) were measured before and at monthly intervals up to 26 months after initiation of CH in 42 patients with terminal renal failure. Body weight (BW), systolic (BPs) and diastolic (BPd) blood pressure were determined simultaneously. With 2 exceptions PA, PRA and PC as well as BW, BPs and BPd showed no significant changes. Following month 2 K was always significantly higher than the starting value while significantly higher Na values were observed in 12 of 26 different test periods (P less than 0.05--less than 0.001). Correlation analysis between the various parameters determined in this study revealed in 16 of 26 different months a significant relationship between PA and PRA (P less than 0.05--less than 0.001) and as expected in 20 of 26 between BPs and BPd (P less than 0.05--less than 0.001). Only at times were punctual correlations seen between any of the remaining parameters. Our results demonstrate that the prime influence of the renin angiotensin system on PA remains unaltered during CH. We conclude that the observed punctual correlations between the various parameters determined in this study are random and do not reflect a true relationship.

摘要

为研究慢性血液透析(CH)对肾上腺醛固酮释放的影响,对42例终末期肾衰竭患者在开始CH之前及开始后每月测定一次血浆醛固酮(PA)、血浆肾素活性(PRA)、血浆皮质醇(PC)以及血清钾(K)和钠(Na)的浓度,同时测定体重(BW)、收缩压(BPs)和舒张压(BPd)。除2例例外,PA、PRA、PC以及BW、BPs和BPd均无显著变化。第2个月后,K始终显著高于起始值,而在26个不同测试期的12个中观察到Na值显著升高(P小于0.05至小于0.001)。本研究测定的各项参数之间的相关性分析显示,在26个不同月份中的16个,PA与PRA之间存在显著关系(P小于0.05至小于0.001),正如预期的那样,在26个中的20个,BPs与BPd之间存在显著关系(P小于0.05至小于0.001)。仅在某些时候,其余参数之间存在即时相关性。我们的结果表明,肾素-血管紧张素系统对PA的主要影响在CH期间保持不变。我们得出结论,本研究中测定的各项参数之间观察到的即时相关性是随机的,并不反映真实关系。

相似文献

1
Control of plasma aldosterone during chronic hemodialysis.慢性血液透析期间血浆醛固酮的控制
Clin Nephrol. 1980 Apr;13(4):172-6.
2
Control of plasma aldosterone in infancy and childhood. A study of plasma renin activity, plasma cortisol and plasma aldosterone.
Helv Paediatr Acta. 1976 Jan;30(4-5):349-56.
3
[The regulation of plasma aldosterone in hemodialysis patients].[血液透析患者血浆醛固酮的调节]
Schweiz Med Wochenschr. 1980 Dec 6;110(49):1882-4.
4
Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.
Clin Nephrol. 1976 Oct;6(4):433-6.
5
Hyperaldosteronism after heart surgery in children. Part II: Regulation of aldosterone secretion.
Padiatr Padol. 1981;16(3):327-33.
6
[Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].[肾素-血管紧张素-醛固酮系统在慢性肾衰竭动脉高血压发病机制中的作用]
Ter Arkh. 1999;71(6):64-7.
7
[Blood pressure and renin in long-term hemodialysis patients].[长期血液透析患者的血压与肾素]
Nihon Jinzo Gakkai Shi. 1996 Jan;38(1):13-21.
8
Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.钠摄入量对清醒犬血浆钾及肾素-血管紧张素-醛固酮系统的影响
Acta Physiol Scand. 2005 Jul;184(3):225-34. doi: 10.1111/j.1365-201X.2005.01452.x.
9
Plasma aldosterone during haemodialysis in patients with terminal renal failure.终末期肾衰竭患者血液透析期间的血浆醛固酮水平
Proc Eur Dial Transplant Assoc. 1973;10(0):332-41.
10
Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.氯沙坦对原发性高血压患者肾素-血管紧张素-醛固酮系统的影响。
J Hum Hypertens. 1995 Apr;9(4):237-43.